The present invention relates to new N-(2,10-dioxatricyclo-[5,3,1,0.sup.3,8 ]-undecane-5-yl-tryptamine compounds and their salts, as well as the preparation of pharmaceuticals which contain these compounds, and a process for producing these compounds.
It has been found that the N-(2,10-dioxa-tricyclo-[5,3,1,0.sup.3,8 ]-undecane-5-yl-tryptamine compounds according to the invention have valuable pharmacological properties, particularly blood pressure lowering effects. These compounds possess an advantageous activity profile with a good therapeutic range and low toxicity. Because of their effects, these new compounds are particularly suited for use as drugs in the treatment of high blood pressure.
USPTO Backgrounds
USPTO Backgrounds